Epidermal growth factor receptor-targeted therapy for pancreatic cancer

被引：110
作者：
Xiong, HQ [1 ]
Abbruzzese, JL [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 05期
关键词：
D O I：
10.1053/sonc.2002.35645
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：31 / 37
页数：7
相关论文
共 66 条
[1]  
ABBRUZZESE JL, 2001, P AN M AM SOC CLIN, V20, pA130
[2]   Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[3]   Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin [J].
Arlt, A ;
Vorndamm, J ;
Breitenbroich, M ;
Fölsch, UR ;
Kalthoff, H ;
Schmidt, WE ;
Schäfer, H .
ONCOGENE, 2001, 20 (07) :859-868
[4]   Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin [J].
Baselga, J ;
Pfister, D ;
Cooper, MR ;
Cohen, R ;
Burtness, B ;
Bos, M ;
D'Andrea, G ;
Seidman, A ;
Norton, L ;
Gunnett, K ;
Falcey, J ;
Anderson, V ;
Waksal, H ;
Mendelsohn, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :904-914
[5]   ANTITUMOR EFFECTS OF DOXORUBICIN IN COMBINATION WITH ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES [J].
BASELGA, J ;
NORTON, L ;
MASUI, H ;
PANDIELLA, A ;
COPLAN, K ;
MILLER, WH ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (16) :1327-1333
[6]  
Bianco C, 2000, CLIN CANCER RES, V6, P4343
[7]   SH2 and SH3-containing adaptor proteins: Redundant or Independent mediators of intracellular signal transduction [J].
Birge, RB ;
Knudsen, BS ;
Besser, D ;
Hanafusa, H .
GENES TO CELLS, 1996, 1 (07) :595-613
[8]   The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[9]  
Bruns CJ, 2000, CANCER RES, V60, P2926
[10]  
Bruns CJ, 2000, CLIN CANCER RES, V6, P1936
1234567